Home » BioTie Therapies Chooses Tripos as Partner in Drug Discovery
BioTie Therapies Chooses Tripos as Partner in Drug Discovery
Tripos, a leading provider of drug discovery chemistry and informatics products
and services, and BioTie Therapies, a Finnish biotech company, have announced
a partnership to enhance BioTie's drug discovery efforts, which include innovative
medicines for the treatment of dependence disorders, inflammatory diseases and
thrombosis. Under the agreement, Tripos will identify and optimize backup series
for one of BioTie's key drug discovery programs.
Yahoo
News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct